Opendata, web and dolomites
H2020 projects about "myeloid"
The page lists 65 projects related to the topic "myeloid".
| # | |||
|---|---|---|---|
| 1 | ApoptoMDS | Hematopoietic stem cell Apoptosis in bone marrow failure and MyeloDysplastic Syndromes: Friend or foe? | 2015 |
| 2 | RhomBioID | Molecular mechanisms of rhomboid-like proteins in human immunity | 2015 |
| 3 | Tolltum | Role, regulation and targeting of nucleic acid-sensing TLRs within the tumour microenvironment | 2015 |
| 4 | NovLeuReg | Identification and characterization of novel essential regulators of acute myeloid leukemia | 2016 |
| 5 | Athero MPh proliferation | Macrophage proliferation and ontogeny in murine models of atherosclerosis | 2016 |
| 6 | ONCOMECHAML | Common Oncogenic Mechanisms in Multi-Partner Translocation Families in Acute Myeloid Leukemia | 2015 |
| 7 | Inflammostrome | Stromal cells as primary drivers of immunopathology: towards targeted disease modification in spondyloarthritis | 2015 |
| 8 | PNANOMED | Personalized Nanomedicines for Leukemia Patients | 2015 |
| 9 | EpiTALL | Dynamic interplay between DNA methylation, histone modifications and super enhancer activity in normal T cells and during malignant T cell transformation | 2015 |
| 10 | HemNichMDS | Functional and Molecular Analyses of the Interplay between Hematopoietic and Mesenchymal Niche Cells in Human Myelodysplastic Syndromes. | 2015 |
| 11 | EXODUS | Light induced spatially EXact and genetically encoded labeling of immune cells for monitoring of lOng Distance and Ultra-compartment Shuttling during autoimmunity and chronic inflammation | 2015 |
| 12 | COMAL | COMAL:COhesin Mutations in Acute Leukemia: from modeling and mechanisms to novel therapeutics | 2015 |
| 13 | APOLs | Role of Apolipoproteins L in immunity and disease | 2015 |
| 14 | AML-VACCiN | Clinical development of a dendritic-cell vaccine therapy for acute myeloid leukaemia | 2016 |
| 15 | EVI1inCancer | Overcoming the epigenetic and therapeutic barrier of EVI1-overexpressing cancers | 2016 |
| 16 | SLIM | Synthetic Lethal Interactions with nucleophosMin 1 | 2016 |
| 17 | CD4DNASP | Cell intrinsic control of CD4 T cell differentiation by cytosolic DNA sensing pathways | 2016 |
| 18 | Immune-senescence | Dual targeting of senescence and tumor immunity for cancer therapy | 2016 |
| 19 | MEDICI | The inflammatory gene expression program in macrophages: An integrative approach for the systematic characterization of transcriptional co-regulators | 2016 |
| 20 | HOXA9 degradome | Deciphering the machinery involved in stability of the transcription factor HOXA9. | 2016 |
| 21 | GENE FOR CURE | Expanding and extending gene therapy of monogenic diseases of the haematopoietic system | 2016 |
| 22 | IMMUNE CELL SWARMS | Innate Immune Cell Swarms: Integrating and Adapting Single Cell and Population Dynamics in Inflamed and Infected Tissues | 2017 |
| 23 | MAMLE | Understanding the mechanisms of human acute myeloid leukaemia (AML) evolution | 2017 |
| 24 | LEUKEMIC-TEs | Unveiling the signature of transposable elements-derived transcripts – the transposcriptome – as a biomarker in human acute myeloid leukemia | 2017 |
| 25 | DNAmethAML | Investigation of aberrant DNA methylation in malignant haematopoiesis | 2018 |
| 26 | THAT IS HUNT | Triggering Haematological Adoptive T-cell Immunotherapy Strategies by HUnting Novel T-cellreceptors | 2018 |
| 27 | ContraNPM1AML | Dissecting to hit the therapeutic targets in nucleophosmin (NPM1)-mutated acute myeloid leukemia | 2017 |
| 28 | iAML-lncTARGET | Targeting the transcriptional landscape in infant AML | 2017 |
| 29 | MITOMAD | Functional characterisation of mitochondrial metabolic adaptations to innate sensing in dendritic cell subsets | 2017 |
| 30 | onCOMBINE | Towards evidence-based combinations of approved and novel cancer drugs | 2017 |
| 31 | TREAT-NPM1-AML | Improving therapy of NPM1-mutated AML | 2017 |
| 32 | AltCheM | In vivo functional screens to decipher mechanisms of stochastically- and mutationally-induced chemoresistance in Acute Myeloid Leukemia | 2018 |
| 33 | ITHACA | Immuno-targeting of human AML quiescent cells by a novel phage display approach. | 2018 |
| 34 | TET2rec | Mechanisms of TET2 DNA demethylase recruitment to specific genomic regions | 2018 |
| 35 | Target5LO | Targeting 5-lipoxygenase in the context of Acute Myeloid Leukemia | 2018 |
| 36 | HifLICs | Acute Myeloid Leukemia Leukemic Initiating Cells: Contribution of hypoxia/HIF pathway to chemoresistance and relapse | 2019 |
| 37 | TFs-HSCs | The identification of the Combinatorial Transcription Factor network exerting different roles in Hematopoietic Stem Cells. | 2019 |
| 38 | LEUKEYOLK | Uncovering the origin and mechanisms of Down syndrome-associated leukaemia through human induced pluripotent stem cell-derived haemopoiesis | 2019 |
| 39 | ProMeta | Non-histone protein acetylation targets of KAT2A in AML | 2018 |
| 40 | PhaseControl | How cellular suicide programmes control phase transitions in fatty liver disease and liver cancer | 2018 |
| 41 | Nano4 | Colorimetric Precision Nanodiagnostics made Fast and Affordable | 2018 |
| 42 | SeroStrat | The first blood test for the early detection and prognosis of Acute Myeloid Leukaemia | 2018 |
| 43 | LapIt | Making AML treatment a clinical reality: A novel anti-IL7 receptor antibody to deliver Lap to 5LO positive cells | 2019 |
| 44 | IT4B-ALL | Therapeutic immunotherapy targeting NG2 and CD22 antigens for MLL-rearranged and MLL-germline B-cell Acute Lymphoblastic Leukemia | 2019 |
| 45 | PML-THERAPY | HARNESSING PML NUCLEAR BODIES FOR LEUKAEMIA THERAPY | 2019 |
| 46 | TALE | Therapeutic Allele Engineering: A novel technology for cell therapy | 2019 |
| 47 | STEP 2 | Spatiotemporal regulation of T-cell Priming | 2019 |
| 48 | PATRES-MDS | Pathogenesis and treatment of splicing factor mutant myelodysplastic syndromes | 2019 |
| 49 | SyLeNCe | Synapses between Leukaemia and its Neighbouring Cells | 2020 |
| 50 | MHT-ImmunoEnhancer | Stimuli-Responsive Nanoplatform to Combine Magnetic Hyperthermia with Immunemodulators Delivery for Glioblastoma Treatment | 2019 |
| 51 | PhotoStem | Photoswitching molecules for the spatiotemporal control of cancer stem cells with light | 2019 |
| 52 | PMLingAML | Using PML nuclear body biology to identify potential AML treatment targets | 2020 |
| 53 | GT-GM1 | Ex vivo gene therapy for GM1-gangliosidosis | 2020 |
| 54 | MacMeninges | Control of Central Nervous Sytem inflammation by meningeal macrophages, and its impairment upon aging | 2019 |
| 55 | MIMIC | Deciphering how microbiota modulate anti-tumor immune responses in checkpoint therapy | 2020 |
| 56 | CAN-IT-BARRIERS | Disruption of systemic and microenvironmental barriers to immunotherapy of antigenic tumors | 2020 |
| 57 | Mitobetes | The role of Von Willebrand Domain-containing Protein 8 in mitochondrial physiology | 2020 |
| 58 | INsTRuCT | INnovative Training in Myeloid Regulatory Cell Therapy | 2020 |
| 59 | TRAIN-OLD | Trained immunity: improving the next generation of vaccines for the older generation | 2019 |
| 60 | MyeFattyLiver | Unravelling the heterogeneity and functions of hepatic myeloid cells in Non-Alcoholic Fatty Liver Disease | 2019 |
| 61 | TO_AITION | A high-dimensional approach for unwinding immune-metabolic causes of cardiovascular disease-depression multimorbidities | 2020 |
| 62 | RECOBIN-PROTACs | Reversible Covalently Binding PROTACs Technology for Protein Degradation in Cancer Therapy | 2020 |
| 63 | Hemstem | Targeting leukaemia by modulating hematopoietic stem cell competitiveness | 2020 |
| 64 | MY MITOCOMPLEX | Functional relevance of mitochondrial supercomplex assembly in myeloid cells | 2021 |
| 65 | SecondCANCERinKIDS | What causes therapy-related malignancies in childhood cancer survivors? Dissecting the etiology of second cancers | 2020 |